Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisei Anan

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|June 4, 2011
Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor-positive breast cancer: the results of a 2-year multicenter open randomized studyKeisei Anan, Shoshu Mitsuyama, Yasuhiro Yanagita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 28, 2018
[Follicle-Stimulating Hormone and Estradiol Levels in Japanese Women Treated with Toremifene and Anastrozole for Two Years - A Retrospective Analysis of Data from a Prospective Randomized Trial]Keisei Anan, Shoshu Mitsuyama, Yasuhiro Yanagita, et al.
Journal of Surgical Oncology|March 6, 2003
Increased dihydropyrimidine dehydrogenase activity in breast cancerKeisei Anan, Shoshu Mitsuyama, Keiyoshi Tamae, et al.
Breast Cancer Research and Treatment|January 12, 2011
Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancerNorikazu Masuda, Hiraji Iwata, Yoshiaki Rai, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2004
Breast cancer in Japanese men: does sex affect prognosis?Keisei Anan, Shoshu Mitsuyama, Kazuyoshi Nishihara, et al.
Anti-Cancer Drugs|January 16, 2010
Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II studyMaki Tanaka, Yasushi Takamatsu, Keisei Anan, et al.
Surgical Case Reports|September 1, 2023
Anaplastic lymphoma kinase-positive inflammatory myofibroblastic tumor of the breast: a case report and review of the literatureYasutaka Kawakita, Keisei Anan, Kanako Kurata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2008
[Adjuvant epirubicin and cyclophosphamide followed by weekly paclitaxel for Japanese women with node-positive breast cancer: a multi-institutional feasibility study]Michiyo Saimura, Shoshu Mitsuyama, Keisei Anan, et al.
Breast Cancer (Tokyo, Japan)|May 23, 2018
Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsyYusuke Watanabe, Keisei Anan, Michiyo Saimura, et al.
Oncology Reports|March 1, 2013
Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: results of the JMTO BC08-01 phase II trialReiki Nishimura, Keisei Anan, Yutaka Yamamoto, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|June 4, 2011
Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor-positive breast cancer: the results of a 2-year multicenter open randomized studyKeisei Anan, Shoshu Mitsuyama, Yasuhiro Yanagita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 28, 2018
[Follicle-Stimulating Hormone and Estradiol Levels in Japanese Women Treated with Toremifene and Anastrozole for Two Years - A Retrospective Analysis of Data from a Prospective Randomized Trial]Keisei Anan, Shoshu Mitsuyama, Yasuhiro Yanagita, et al.
Journal of Surgical Oncology|March 6, 2003
Increased dihydropyrimidine dehydrogenase activity in breast cancerKeisei Anan, Shoshu Mitsuyama, Keiyoshi Tamae, et al.
Breast Cancer Research and Treatment|January 12, 2011
Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancerNorikazu Masuda, Hiraji Iwata, Yoshiaki Rai, et al.
Breast Cancer (Tokyo, Japan)|November 20, 2004
Breast cancer in Japanese men: does sex affect prognosis?Keisei Anan, Shoshu Mitsuyama, Kazuyoshi Nishihara, et al.
Anti-Cancer Drugs|January 16, 2010
Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II studyMaki Tanaka, Yasushi Takamatsu, Keisei Anan, et al.
Surgical Case Reports|September 1, 2023
Anaplastic lymphoma kinase-positive inflammatory myofibroblastic tumor of the breast: a case report and review of the literatureYasutaka Kawakita, Keisei Anan, Kanako Kurata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2008
[Adjuvant epirubicin and cyclophosphamide followed by weekly paclitaxel for Japanese women with node-positive breast cancer: a multi-institutional feasibility study]Michiyo Saimura, Shoshu Mitsuyama, Keisei Anan, et al.
Breast Cancer (Tokyo, Japan)|May 23, 2018
Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsyYusuke Watanabe, Keisei Anan, Michiyo Saimura, et al.
Oncology Reports|March 1, 2013
Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: results of the JMTO BC08-01 phase II trialReiki Nishimura, Keisei Anan, Yutaka Yamamoto, et al.
Pageof 5